LAX.SH
SAT KARTAR LIFE LIMITED·Healthcare Companies·Pharmaceuticals & Biotechnology Companies
Price
137.3
+4.68%O:129.05
H:137.65
L:126.25
C:137.3
52W Range
110.3219.8
+24%/-38%
Market Cap
₹216.87 Cr
Traded: ₹0.39 Cr (0.18%) 0.0x
Free Float: ₹61.70 Cr (0.63% of FF traded)
Volume · 60D trend
29.6 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
1W:+0% 1M:-25% 3M:+17% 6M:-11% 12M:-7%
RS Score
SEEM
NOUS
BNF
SMA Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
P/E--
P/B3.2
P/S--
EV/EBIT--
Business Strength
ROE--
ROCE--
OPM--
NPM--
Growth (3Y CAGR)
EPS--
Sales--
Profit--
3Y Return--
Balance Sheet
Debt/Equity--
Debt2.3 Cr
Pledge--
CWIP/Fixed Asset--
Cash Position
CFO/NP--
FCF--
FCF 3Y Avg--
Cash/MCap--
Others
Div Yield0.5%
Div Payout--
Cash Conv. Cycle--
Tradeable Free Float28.5%
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -- | -- | -- | -- |
| Profit | -- | -- | -- | -- | -- | -- |
| Return | -- | -- | -- | -3.0% | -- | -- |
| ROE | -- | -- | -- | -- | -- | -- |
Quarterly Results
Mar 2026
5 MayRev
▲111 Cr
+28% YoY+23% QoQ
OPM13.0%
NPM9.0%
PAT
--▲10 Cr
EPS
+64% YoY▲6.2
Sep 2025
Rev
90 Cr
----
OPM10.9%
NPM8.1%
PAT
--7 Cr
EPS
--4.6
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Debt / Equity--
Interest Coverage--x
Promoter Pledge--
Borrowings--
Efficiency
Receivable Days days
Inventory Days days
Payable Days days
Cash Conversion cycle days
Cash Position
Operating Cash Flow--
Investing Cash Flow--
Financing Cash Flow--
Free Cash Flow--
Detailed Financials
Mar 2026 | Sep 2025 | |
|---|---|---|
| Sales | 111 | 90 |
| Expenses | 96 | 80 |
| Operating Profit | 15 | 10 |
| Other Income | 1 | 2 |
| Interest | 0 | 0 |
| Depreciation | 2 | 1 |
| Profit Before Tax | 13 | 10 |
| Tax % | 25.0% | 27.8% |
| Net Profit | 10 | 7 |
| Exceptional Items | -- | -- |
| EPS (Rs) | 6.2 | 4.6 |
| Sales Growth (YoY) | 27.6% | -- |
| Sales Growth (QoQ) | 23.3% | -- |
| OP Growth (YoY) | -- | -- |
| OP Growth (QoQ) | -- | -- |
| Profit Growth (YoY) | -- | -- |
| EPS Growth (YoY) | 63.7% | -- |
| EPS Growth (QoQ) | 34.0% | -- |
| OP Margin | 13.5% | 10.9% |
| Net Margin | 9.0% | 8.1% |
| Material Cost % | 8.2% | -- |
| Employee Cost % | 10.4% | -- |
| P/S | -- | -- |
| P/E | -- | -- |
| P/B | 3.19 | -- |
Annual Reports
12025
nseDownload